{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T18:14:04Z","timestamp":1778350444092,"version":"3.51.4"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,6,15]]},"DOI":"10.1093\/infdis\/jit105","type":"journal-article","created":{"date-parts":[[2013,3,13]],"date-time":"2013-03-13T04:29:47Z","timestamp":1363148987000},"page":"1888-1897","source":"Crossref","is-referenced-by-count":69,"title":["Safety and Immunogenicity of Modified Vaccinia Ankara in Hematopoietic Stem Cell Transplant Recipients: A Randomized, Controlled Trial"],"prefix":"10.1093","volume":"207","author":[{"given":"Stephen R.","family":"Walsh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marissa B.","family":"Wilck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Dominguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elise","family":"Zablowsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shringkhala","family":"Bajimaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa S.","family":"Gagne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly A.","family":"Verrill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane A.","family":"Kleinjan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alka","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aruna","family":"Acharyya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph H.","family":"Antin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael S.","family":"Seaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raphael","family":"Dolin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsey R.","family":"Baden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2013,3,12]]},"reference":[{"key":"key\n\t\t\t\t20170702142152_JIT105C1","volume-title":"Smallpox and its eradication","author":"Fenner","year":"1988"},{"key":"key\n\t\t\t\t20170702142152_JIT105C2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0147-9571(03)00025-0","article-title":"Smallpox vaccination and bioterrorism with pox viruses","volume":"26","author":"Mayr","year":"2003","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20170702142152_JIT105C3","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1099\/0022-1317-72-5-1031","article-title":"Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence","volume":"72","author":"Meyer","year":"1991","journal-title":"J Gen Virol"},{"key":"key\n\t\t\t\t20170702142152_JIT105C4","doi-asserted-by":"crossref","first-page":"8562","DOI":"10.1016\/j.vaccine.2007.10.017","article-title":"Clinical and immunologic responses to multiple doses of IMVAMUNE (Modified Vaccinia Ankara) followed by Dryvax challenge","volume":"25","author":"Frey","year":"2007","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170702142152_JIT105C5","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.vaccine.2006.10.047","article-title":"Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax challenge in vaccinia-na\u00efve and vaccinia-immune individuals","volume":"25","author":"Parrino","year":"2007","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170702142152_JIT105C6","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.vaccine.2005.11.022","article-title":"Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine","volume":"24","author":"Vollmar","year":"2006","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170702142152_JIT105C7","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.vaccine.2009.11.030","article-title":"A randomized, double-blind, dose-finding phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE","volume":"28","author":"von Krempelhuber","year":"2010","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170702142152_JIT105C8","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1086\/651561","article-title":"Safety and immunogenicity of modified vaccinia Ankara (ACAM3000): effect of dose and route of administration","volume":"201","author":"Wilck","year":"2010","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170702142152_JIT105C9","first-page":"375","article-title":"The smallpox vaccination strain MVA: marker, genetic structure, experience gained with the parenteral vaccination and behavior in organisms with a debilitated defence mechanism [author's translation; in German]","volume":"167","author":"Mayr","year":"1978","journal-title":"Zentralbl Bakteriol B"},{"key":"key\n\t\t\t\t20170702142152_JIT105C10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1006\/viro.1998.9123","article-title":"The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses","volume":"244","author":"Antoine","year":"1998","journal-title":"Virology"},{"issue":"Pt 2","key":"key\n\t\t\t\t20170702142152_JIT105C11","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1099\/0022-1317-79-2-347","article-title":"Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells","volume":"79","author":"Drexler","year":"1998","journal-title":"J Gen Virol"},{"key":"key\n\t\t\t\t20170702142152_JIT105C12","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1099\/vir.0.83156-0","article-title":"Genomic sequence of chorioallantois vaccinia virus Ankara, the ancestor of modified vaccinia virus Ankara","volume":"88","author":"Meisinger-Henschel","year":"2007","journal-title":"J Gen Virol"},{"key":"key\n\t\t\t\t20170702142152_JIT105C13","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1099\/0022-1317-79-5-1159","article-title":"Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine","volume":"79","author":"Blanchard","year":"1998","journal-title":"J Gen Virol"},{"key":"key\n\t\t\t\t20170702142152_JIT105C14","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/viro.1997.8845","article-title":"Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line","volume":"238","author":"Carroll","year":"1997","journal-title":"Virology"},{"key":"key\n\t\t\t\t20170702142152_JIT105C15","doi-asserted-by":"crossref","first-page":"10847","DOI":"10.1073\/pnas.89.22.10847","article-title":"Nonreplicating vaccinia vector efficiently expresses recombinant genes","volume":"89","author":"Sutter","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20170702142152_JIT105C16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jlb.58.1.1","article-title":"Poxvirus-based vaccine candidates for cancer, AIDS, and other infectious diseases","volume":"58","author":"Perkus","year":"1995","journal-title":"J Leukoc Biol"},{"key":"key\n\t\t\t\t20170702142152_JIT105C17","doi-asserted-by":"crossref","first-page":"v","DOI":"10.1016\/S0264-410X(01)00171-2","article-title":"MVA: a cuckoo in the vaccine nest?","volume":"19","author":"Stittelaar","year":"2001","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170702142152_JIT105C18","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1586\/erv.11.79","article-title":"Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors","volume":"10","author":"Walsh","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"key\n\t\t\t\t20170702142152_JIT105C19","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1586\/14760584.7.7.889","article-title":"Clinical development of MVA-based therapeutic cancer vaccines","volume":"7","author":"Acres","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"key\n\t\t\t\t20170702142152_JIT105C20","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1517\/14712590802567298","article-title":"Development of modified vaccinia Ankara-5T4 as specific immunotherapy for advanced human cancer","volume":"8","author":"Tykodi","year":"2008","journal-title":"Expert Opin Biol Ther"},{"key":"key\n\t\t\t\t20170702142152_JIT105C21","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1089\/aid.2006.0226","article-title":"Evaluation of modified vaccinia virus Ankara as an alternative vaccine against smallpox in chronically HIV type 1-infected individuals undergoing HAART","volume":"23","author":"Cosma","year":"2007","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key\n\t\t\t\t20170702142152_JIT105C22","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/infdis\/jis753","article-title":"Safety, immunogenicity, and surrogate markers of clinical efficacy for modified vaccinia Ankara as a smallpox vaccine in HIV-infected subjects","volume":"207","author":"Greenberg","year":"2013","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170702142152_JIT105C23","doi-asserted-by":"crossref","first-page":"6883","DOI":"10.1016\/j.vaccine.2008.09.084","article-title":"Safety and immunogenicity of recombinant poxvirus HIV-1 vaccines in young adults on highly active antiretroviral therapy","volume":"26","author":"Greenough","year":"2008","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170702142152_JIT105C24","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/135965350501000212","article-title":"Therapeutic vaccination of HIV-1-infected patients on HAART with a recombinant HIV-1 nef-expressing MVA: safety, immunogenicity and influence on viral load during treatment interruption","volume":"10","author":"Harrer","year":"2005","journal-title":"Antivir Ther"},{"key":"key\n\t\t\t\t20170702142152_JIT105C25","first-page":"1","article-title":"Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC)","volume":"52","author":"Wharton","year":"2003","journal-title":"MMWR Recomm Rep"},{"key":"key\n\t\t\t\t20170702142152_JIT105C26","first-page":"1","article-title":"General recommendations on immunization\u2014recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"60","author":"Kroger","year":"2011","journal-title":"MMWR Recomm Rep"},{"key":"key\n\t\t\t\t20170702142152_JIT105C27","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/QCO.0b013e328307c7c5","article-title":"Vaccination after stem cell transplant: a review of recent developments and implications for current practice","volume":"21","author":"Wilck","year":"2008","journal-title":"Curr Opin Infect Dis"},{"key":"key\n\t\t\t\t20170702142152_JIT105C28","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/aje\/kwh269","article-title":"Myopericarditis following smallpox vaccination","volume":"160","author":"Arness","year":"2004","journal-title":"Am J Epidemiol"},{"issue":"Suppl 3","key":"key\n\t\t\t\t20170702142152_JIT105C29","doi-asserted-by":"crossref","first-page":"S242","DOI":"10.1086\/524747","article-title":"Myocarditis, pericarditis, and dilated cardiomyopathy after smallpox vaccination among civilians in the United States, January-October 2003","volume":"46","author":"Morgan","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"Suppl 3","key":"key\n\t\t\t\t20170702142152_JIT105C30","doi-asserted-by":"crossref","first-page":"S234","DOI":"10.1086\/524745","article-title":"Ischemic cardiac events during the Department of Health and Human Services Smallpox Vaccination Program, 2003","volume":"46","author":"Swerdlow","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170702142152_JIT105C31","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170702142152_JIT105C32","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.vaccine.2009.01.010","article-title":"Immunogenicity of recombinant modified vaccinia Ankara following a single or multi-dose vaccine regimen in rhesus monkeys","volume":"27","author":"Grandpre","year":"2009","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170702142152_JIT105C33","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1016\/j.vaccine.2009.05.077","article-title":"Diverse recognition of conserved orthopoxvirus CD8+ T cell epitopes in vaccinated rhesus macaques","volume":"27","author":"Walsh","year":"2009","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170702142152_JIT105C34","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1200\/JCO.2009.25.0597","article-title":"Overall survival analysis of a phase II randomized controlled trial of a poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer","volume":"28","author":"Kantoff","year":"2010","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20170702142152_JIT105C35","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.vaccine.2012.10.093","article-title":"Impact of anti-orthopoxvirus neutralizing antibodies induced by a heterologous prime-boost HIV-1 vaccine on insert-specific immune responses","volume":"31","author":"Walsh","year":"2012","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170702142152_JIT105C36","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.bbmt.2010.10.002","article-title":"Seroprotective titres against 2009 H1N1 influenza A virus after vaccination in allogeneic hematopoietic stem cell transplantation recipients","volume":"17","author":"Issa","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"key\n\t\t\t\t20170702142152_JIT105C37","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4269\/ajtmh.1972.21.214","article-title":"A prospective study of serum antibody and protection against smallpox","volume":"21","author":"Mack","year":"1972","journal-title":"Am J Trop Med Hyg"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/207\/12\/1888\/18068647\/jit105.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T06:30:53Z","timestamp":1688106653000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article-lookup\/doi\/10.1093\/infdis\/jit105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,12]]},"references-count":37,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2013,3,12]]},"published-print":{"date-parts":[[2013,6,15]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jit105","relation":{},"ISSN":["1537-6613","0022-1899"],"issn-type":[{"value":"1537-6613","type":"electronic"},{"value":"0022-1899","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3,12]]}}}